Welcome!

News Feed Item

The Worldwide Market for Molecular Diagnostics 6-month Update

NEW YORK, March 25, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

The Worldwide Market for Molecular Diagnostics 6-month Update
http://www.reportlinker.com/p02051943/The-Worldwide-Market-for-Molecular-Diagnostics-6-month-Update.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

Molecular diagnostics is becoming a dominant platform in clinical medicine and represents one of the fastest growing segments of the diagnostics market. Many molecular tests are CE Marked and FDA-cleared and many more are in development. However many more unique tests have been launched as test services, especially for cancer management and infectious disease epidemiology.

In light of the amount of activity in test development and regulatory and reimbursement challenges in 2013, Kalorama Information presents this updated review of molecular diagnostics with an emphasis on the last six months of 2013: July – December. This report highlights trends and developments that portent the evolution of molecular tests and technologies. The ensemble of consumer demand, technological advances and market forces create a dynamic, energetic and fast-moving environment for new tests and companies.

Though focused on the developments of the last six months, coverage is substantial.

As part of its coverage, this report provides, current market size and forecasts for Molecular Diagnostic Segments, including:

-Microbiology
-Histology
-Blood Screening
-Prenatal
-Coagulation
-Inherited Diseases
-Tissue Typing
-Cancer Markers
-Pharmacodiagnostics
- CTCs

The report provides breakout of key market segments for molecular diagnostic markets in world regions, including developed nations and emerging nations.

In addition the following important trend information is also provided:

-Selected Sequencing-Based Innovations July-December 2013
-Selected Molecular Diagnostics Collaborations, July-December 2013
-Selected Molecular Diagnostics Licensing Agreements, July-December 2013
-Selected Molecular Diagnostics Distribution Agreements, July-December 2013
-Regulatory and Reimbursement Update
-Molecular Test Revenues of The Top Companies, 2012-2013

Market analysis in this report covers world markets for in vitro diagnostics, however the reader will find a bias toward the developed areas of the globe -- North America and Western Europe. However public health and infectious disease are a growing global problem and where possible the report covers IVD products related to the globalization of diseases. The information presented in this report is derived primarily from company reports and other publicly available information published by government, and medical organizations.
CHAPTER ONE: MARKET OVERVIEW
Background
Scope and Methodology
Size And Growth Of The Market, Worldwide
Regulatory and Reimbursement Update
Company Moves
Top Suppliers and Niche players
Test Services Continue to Expand

Point of View
CHAPTER TWO: SEQUENCING MOVES TO THE CLINIC
Background
Cancer gets more personal
Pathogen sequencing
CHAPTER THREE: THE MARKET FOR BLOOD-BASED MARKERS IN CANCER
Background
Blood-based analyses
Circulating Tumor Cells
CHAPTER FOUR: THE MARKET FOR MOLECULAR ASSAYS IN HEMATOLOGY
Background
CHAPTER FIVE: THE MARKET FOR MOLECULAR ASSAYS IN COAGULATION AND CARDIAC CARE
Background
Coagulation Market Analysis
CHAPTER SIX: THE MARKET FOR MOLECULAR ASSAYS IN HISTOPATHOLOGY/CYTOLOGY
Background
Molecular Histology
Market Analysis
HPV Testing
CHAPTER SEVEN: THE MARKET FOR MOLECULAR ASSAYS IN MICROBIOLOGY/VIROLOGY
Overview
HIV/AIDS
Hepatitis
Sexually Transmitted Diseases
Hospital Acquired Infections
Respiratory Tract Infections

Tuberculosis
Blood Culture
Miscellaneous
Mass Spectrometry
CHAPTER EIGHT: THE MARKET FOR MOLECULAR ASSAYS IN BLOOD TRANSFUSION SCREENING
Background
Blood Pathogen Screening
Blood Typing
CHAPTER NINE: THE MARKET FOR MOLECULAR ASSAYS IN BLOOD TRANSFUSION SCREENING
Background
Blood Pathogen Screening
Blood Typing
CHAPTER TEN: The Market For Molecular Assays For Inherited Diseases
Market Analysis
CHAPTER ELEVEN: The Market For Molecular Assays In Organ Transplant
Management
Market Analysis
CHAPTER TWELVE: The Market For Molecular Assays
In Prenatal And Neonatal Testing
Market Analysis
CHAPTER THIRTEEN: Forecast: An Eye For The Next Six Months
– January To June 2014
Market Analysis

List of Tables

CHAPTER ONE: MARKET OVERVIEW
Table 1-1: Exchange Rate Fluctuations, 2009-2013
Table 1-2: Worldwide Molecular Test Sales, 2012-2013, by Test Segment (Growth Rates in
Molecular Diagnostics Compared (Microbiology, Histology, Blood Screening, Prenatal,
Coagulation, Inherited Diseases, Tissue Typing, Cancer Markers, Pharmacodiagnostics, CTCs)
Table 1-3: Worldwide Molecular Test Sales, 2012-2013, By Geography (North America, Western Europe, Japan, China, Latin America, ROW)
Table 1-3: Worldwide Molecular Test Sales, 2012-2013, By Geography (North America, Western Europe, Japan, China, Latin America, ROW)
Table 1-4: Selected Advanced Test Innovations, July –December 2013
Table 1-5: Selected Company Purchases And Joint Ventures, July-December 2013
Table 1-6: Selected collaborations, July-December 2013
Table 1-7: Selected licensing agreements, July-December 2013
Table 1-8: Selected distribution agreements, July-December 2013
Table 1-9: Molecular Test Revenues of The Top Companies, 2012-2013
Table 1-9: Molecular Test Revenues of The Top Companies, 2012 Vs. 2013
Table 1-10: Selected Molecular Test Services, Sales 2012-2013
Table 1-11: Selected Molecular Test Services, July-December 2013

CHAPTER TWO: SEQUENCING MOVES TO THE CLINIC
Table 2-1: Major Sequencing Platforms
Table 2-2: Selected Sequencing-Based Innovations July-December 2013
CHAPTER THREE: THE MARKET FOR BLOOD-BASED MARKERS IN CANCER
Table 3-1: Selected Innovation In Blood-Based Cancer Tests, July-December 2013
Table 3-2: Selected Non-Invasive Molecular Cancer Tests In Development, July-December 2013
Table 3-3: Selected Innovations In Circulating Tumor Cell Testing, July-December 2013
CHAPTER FOUR: THE MARKET FOR MOLECULAR ASSAYS IN HEMATOLOGY
Table 4-1: Selected Innovations In Molecular Hematological Tests, July-December 2013
CHAPTER FIVE: THE MARKET FOR MOLECULAR ASSAYS IN COAGULATION AND CARDIAC CARE
Table 5-1: Selected Tests For Coagulation And Cardiac Disease Molecular Markers July- December 2013
CHAPTER SIX: THE MARKET FOR MOLECULAR ASSAYS IN HISTOPATHOLOGY/CYTOLOGY
Table 6-1: Worldwide Molecular Histology/Cytology Sales, 2012-2013
Table 6-2: Selected Molecular Histology Innovations, July-December 2013
Table 6-3: Selected Innovations In Molecular Tissue Sample Preparation, July – December 2013
Table 6-4: Selected Innovations In HPV Testing, July –December 2013
CHAPTER SEVEN: THE MARKET FOR MOLECULAR ASSAYS IN MICROBIOLOGY/VIROLOGY
Table 7-1: Molecular Test Sales, Microbiolog/Virology, 2012-2013
Table 7-2: Selected Hepatitis Test Innovations, July-December 2013
Table 7-3: Selected Innovations In Molecular STD Testing, July-December 2013
Table 7-4: Selected Molecular HAI Test Innovations, July-December 2013
Table 7-5: Selected Respiratory Tract Test Innovations, July-December 2013
Table 7-6: Selected Microbiology Innovations, July-December 2013
CHAPTER NINE: THE MARKET FOR MOLECULAR ASSAYS FOR INHERITED DISEASES
Table 9-1: Selected Innovations In Molecular Tests For Inherited Diseases, July – December 2013
CHAPTER ELEVEN: The Market For Molecular Assays In Organ Transplant Management
Table 11-1: Selected Innovations In Prenatal Testing, July-December 2013

To order this report: The Worldwide Market for Molecular Diagnostics 6-month Update
http://www.reportlinker.com/p02051943/The-Worldwide-Market-for-Molecular-Diagnostics-6-month-Update.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
SYS-CON Events announced today that N3N will exhibit at SYS-CON's @ThingsExpo, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. N3N’s solutions increase the effectiveness of operations and control centers, increase the value of IoT investments, and facilitate real-time operational decision making. N3N enables operations teams with a four dimensional digital “big board” that consolidates real-time live video feeds alongside IoT sensor data a...
Mobile device usage has increased exponentially during the past several years, as consumers rely on handhelds for everything from news and weather to banking and purchases. What can we expect in the next few years? The way in which we interact with our devices will fundamentally change, as businesses leverage Artificial Intelligence. We already see this taking shape as businesses leverage AI for cost savings and customer responsiveness. This trend will continue, as AI is used for more sophistica...
Today most companies are adopting or evaluating container technology - Docker in particular - to speed up application deployment, drive down cost, ease management and make application delivery more flexible overall. As with most new architectures, this dream takes significant work to become a reality. Even when you do get your application componentized enough and packaged properly, there are still challenges for DevOps teams to making the shift to continuous delivery and achieving that reducti...
What is the best strategy for selecting the right offshore company for your business? In his session at 21st Cloud Expo, Alan Winters, U.S. Head of Business Development at MobiDev, will discuss the things to look for - positive and negative - in evaluating your options. He will also discuss how to maximize productivity with your offshore developers. Before you start your search, clearly understand your business needs and how that impacts software choices.
Real IoT production deployments running at scale are collecting sensor data from hundreds / thousands / millions of devices. The goal is to take business-critical actions on the real-time data and find insights from stored datasets. In his session at @ThingsExpo, John Walicki, Watson IoT Developer Advocate at IBM Cloud, will provide a fast-paced developer journey that follows the IoT sensor data from generation, to edge gateway, to edge analytics, to encryption, to the IBM Bluemix cloud, to Wa...
Enterprises are moving to the cloud faster than most of us in security expected. CIOs are going from 0 to 100 in cloud adoption and leaving security teams in the dust. Once cloud is part of an enterprise stack, it’s unclear who has responsibility for the protection of applications, services, and data. When cloud breaches occur, whether active compromise or a publicly accessible database, the blame must fall on both service providers and users. In his session at 21st Cloud Expo, Ben Johnson, C...
Most of the time there is a lot of work involved to move to the cloud, and most of that isn't really related to AWS or Azure or Google Cloud. Before we talk about public cloud vendors and DevOps tools, there are usually several technical and non-technical challenges that are connected to it and that every company needs to solve to move to the cloud. In his session at 21st Cloud Expo, Stefano Bellasio, CEO and founder of Cloud Academy Inc., will discuss what the tools, disciplines, and cultural...
SYS-CON Events announced today that Fusic will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Fusic Co. provides mocks as virtual IoT devices. You can customize mocks, and get any amount of data at any time in your test. For more information, visit https://fusic.co.jp/english/.
SYS-CON Events announced today that Massive Networks, that helps your business operate seamlessly with fast, reliable, and secure internet and network solutions, has been named "Exhibitor" of SYS-CON's 21st International Cloud Expo ®, which will take place on Oct 31 - Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. As a premier telecommunications provider, Massive Networks is headquartered out of Louisville, Colorado. With years of experience under their belt, their team of...
21st International Cloud Expo, taking place October 31 - November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA, will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud strategy. Me...
SYS-CON Events announced today that MIRAI Inc. will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. MIRAI Inc. are IT consultants from the public sector whose mission is to solve social issues by technology and innovation and to create a meaningful future for people.
With the rise of DevOps, containers are at the brink of becoming a pervasive technology in Enterprise IT to accelerate application delivery for the business. When it comes to adopting containers in the enterprise, security is the highest adoption barrier. Is your organization ready to address the security risks with containers for your DevOps environment? In his session at @DevOpsSummit at 21st Cloud Expo, Chris Van Tuin, Chief Technologist, NA West at Red Hat, will discuss: The top security r...
SYS-CON Events announced today that Enroute Lab will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Enroute Lab is an industrial design, research and development company of unmanned robotic vehicle system. For more information, please visit http://elab.co.jp/.
IBM helps FinTechs and financial services companies build and monetize cognitive-enabled financial services apps quickly and at scale. Hosted on IBM Bluemix, IBM’s platform builds in customer insights, regulatory compliance analytics and security to help reduce development time and testing. In his session at 21st Cloud Expo, Lennart Frantzell, a Developer Advocate with IBM, will discuss how these tools simplify the time-consuming tasks of selection, mapping and data integration, allowing devel...
SYS-CON Events announced today that Mobile Create USA will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Mobile Create USA Inc. is an MVNO-based business model that uses portable communication devices and cellular-based infrastructure in the development, sales, operation and mobile communications systems incorporating GPS capabi...